{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:33:49Z","timestamp":1787240029005,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"General Program of the Jiangsu Provincial Health Commission","award":["M2022088"],"award-info":[{"award-number":["M2022088"]}]},{"name":"Youth Program of the Wuxi Municipal Health Commission","award":["Q202373"],"award-info":[{"award-number":["Q202373"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373644"],"award-info":[{"award-number":["82373644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173586"],"award-info":[{"award-number":["82173586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Liver fibrosis caused by\n                      <jats:italic>Schistosoma japonicum<\/jats:italic>\n                      may continue to progress even following successful praziquantel chemotherapy. Although liver biopsy remains the gold standard for diagnosis of liver fibrosis, its invasiveness limits clinical applications. Conventional non-invasive indices, such as aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) index, often show suboptimal performance in schistosomiasis-related cases. This study aimed to develop and validate a machine learning (ML)-based model using epidemiological and laboratory data to identify liver fibrosis in individuals with prior\n                      <jats:italic>S. japonicum<\/jats:italic>\n                      infection, as a step toward precision management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Data were obtained from the Jiangsu\n                      <jats:italic>S. japonicum<\/jats:italic>\n                      Infection Cohort (Jiangsu Province, China), involving 6158 participants with a documented history of infection who completed follow-up assessments during 2021\u20132022. Modeling variables were selected using LASSO regression and variance inflation factor analysis. Five ML models (k-nearest neighbor, logistic regression, support vector machine, decision tree, and extreme gradient boosting (XGBoost)) were evaluated. Model performance was compared against APRI and FIB-4 using the area under the receiver operating characteristic curve (AUC), decision curve analysis (DCA), and shapley additive explanations (SHAP) for interpretability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the validation set, the XGBoost model demonstrated the highest diagnostic performance with an AUC of 0.854 (95% confidence interval (\n                      <jats:italic>CI):<\/jats:italic>\n                      0.826\u20130.881), outperforming other ML models (AUC range: 0.609\u20130.776). This was significantly superior to FIB-4 (AUC\u2009=\u20090.514) and APRI (AUC\u2009=\u20090.516) (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). DCA confirmed that the XGBoost model provided a substantial clinical net benefit across a broad range of threshold probabilities. According to Shapley additive explanations\u00a0analysis, variables such as alcohol intake (mean SHAP value\u2009=\u20090.401), gamma-glutamyl transferase (0.295), and triglycerides (0.292) were the most influential predictors of liver fibrosis risk.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The XGBoost-based model offers a robust, non-invasive tool for identifying liver fibrosis in individuals with prior\n                      <jats:italic>S. japonicum<\/jats:italic>\n                      infection, with alcohol intake, gamma-glutamyl transferase, and triglycerides identified as the critical predictors. By outperforming traditional indices and leveraging routinely available data, this model represents a promising advancement toward precision management of individuals with prior\n                      <jats:italic>S. japonicum<\/jats:italic>\n                      infection, offering a scalable approach for early intervention, risk\u2011stratified assessment, and monitoring of hepatic morbidity in post\u2011transmission settings.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40249-026-01485-y","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T03:05:22Z","timestamp":1787195122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a machine learning-based model for identifying liver fibrosis in individuals with prior Schistosoma japonicum infection: a step toward precision management"],"prefix":"10.1186","volume":"15","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianFeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiMin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuiXin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaiYong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"1","key":"1485_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Primers. 2018;4(1):13.","journal-title":"Nat Rev Dis Primers"},{"key":"1485_CR2","unstructured":"World Health Organization. Schistosomiasis. Geneva: World Health Organization; 2026. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis. Accessed 4 Jul 2026."},{"key":"1485_CR3","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2024.0522","author":"B Savassi","year":"1941","unstructured":"Savassi B, Kincaid-Smith J, Courtin D, Ibikounle M, Toulza E, Galinier R, et al. African zoonotic schistosomiasis: a paradigm shift. Philos Trans R Soc Lond B Biol Sci. 1941. https:\/\/doi.org\/10.1098\/rstb.2024.0522.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"1485_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1556\/1886.2024.00013","volume":"14","author":"E Ponzo","year":"2024","unstructured":"Ponzo E, Midiri A, Manno A, Pastorello M, Biondo C, Mancuso G. Insights into the epidemiology, pathogenesis, and differential diagnosis of schistosomiasis. Eur J Microbiol Immunol (Bp). 2024;14(2):86\u201396.","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"1","key":"1485_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s40249-025-01373-x","volume":"14","author":"Z Lei","year":"2025","unstructured":"Lei Z, Zhou S, Su C, Wu G. Mechanisms underlying persistent liver fibrosis progression in Schistosoma-infected individuals post-treatment. Infect Dis Poverty. 2025;14(1):103.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"1485_CR6","first-page":"18","volume":"23","author":"LY Wen","year":"2011","unstructured":"Wen LY, Yan XL, Zhang JF, Li LS, Lin LJ, Huang SY, et al. Strategy of solidification and surveillance for schistosomiasis in transmission-interrupted provinces in China. Chin J Schistosomiasis Contr. 2011;23(1):18\u201321.","journal-title":"Chin J Schistosomiasis Contr."},{"issue":"8","key":"1485_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009578","volume":"15","author":"W Wang","year":"2021","unstructured":"Wang W, Bergquist R, King CH, Yang K. Elimination of schistosomiasis in China: current status and future prospects. PLoS Negl Trop Dis. 2021;15(8):e0009578.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1485_CR8","first-page":"221","volume":"36","author":"L Zhang","year":"2024","unstructured":"Zhang L, He J, Yang F, Dang H, Li Y, Guo S, et al. Progress of schistosomiasis control in People\u2019s Republic of China in 2023. Chin J Schistosomiasis Contr. 2024;36(3):221\u20137 (in Chinese).","journal-title":"Chin J Schistosomiasis Contr"},{"issue":"3","key":"1485_CR9","first-page":"223","volume":"37","author":"J He","year":"2025","unstructured":"He J, Zhang L, Yang F, Dang H, Li Y, Guo S, et al. Progress of schistosomiasis control in the People\u2019s Republic of China in 2024. Chin J Schistosomiasis Contr. 2025;37(3):223\u201331 (in Chinese).","journal-title":"Chin J Schistosomiasis Contr"},{"issue":"5","key":"1485_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000685","volume":"4","author":"EJ Carlton","year":"2010","unstructured":"Carlton EJ, Hsiang M, Zhang Y, Johnson S, Hubbard A, Spear RC. The impact of Schistosoma japonicum infection and treatment on ultrasound-detectable morbidity: a five-year cohort study in Southwest China. PLoS Negl Trop Dis. 2010;4(5):e685.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"1485_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0035-9203(02)90386-X","volume":"96","author":"YS Li","year":"2002","unstructured":"Li YS, Sleigh AC, Li Y, Tanner M, Dessein A, Williams GM, et al. Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China. Trans R Soc Trop Med Hyg. 2002;96(4):438\u201343.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"1485_CR12","first-page":"477","volume":"25","author":"AH Yin","year":"2013","unstructured":"Yin AH, Hua HY, Sun GX, Xu MG, Zhou WE, Zhu WC, et al. Survey on newly-developed advanced schistosomiasis patients in schistosomiasis transmission-interrupted areas. Chin J Schistosomiasis Contr. 2013;25(5):477\u201380 (in Chinese).","journal-title":"Chin J Schistosomiasis Contr."},{"key":"1485_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10121532","author":"F Hu","year":"2021","unstructured":"Hu F, Xie SY, Yuan M, Li YF, Li ZJ, Gao ZL, et al. The dynamics of hepatic fibrosis related to schistosomiasis and its risk factors in a cohort of China. Pathogens. 2021. https:\/\/doi.org\/10.3390\/pathogens10121532.","journal-title":"Pathogens"},{"issue":"6","key":"1485_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.4254\/wjh.v15.i6.755","volume":"15","author":"CY Zhang","year":"2023","unstructured":"Zhang CY, Liu S, Yang M. Treatment of liver fibrosis: past, current, and future. World J Hepatol. 2023;15(6):755\u201374.","journal-title":"World J Hepatol"},{"key":"1485_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijid.2016.10.024","volume":"54","author":"DU Olveda","year":"2017","unstructured":"Olveda DU, Inobaya M, Olveda RM, Vinluan ML, Ng SK, Weerakoon K, et al. Diagnosing schistosomiasis-induced liver morbidity: implications for global control. Int J Infect Dis. 2017;54:138\u201344.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"1485_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10238-022-00799-z","volume":"23","author":"AB Chowdhury","year":"2023","unstructured":"Chowdhury AB, Mehta KJ. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clin Exp Med. 2023;23(2):273\u201385.","journal-title":"Clin Exp Med"},{"key":"1485_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/poh2.38","volume":"2","author":"T Wang","year":"2023","unstructured":"Wang T, Hua HY, Zhang JF, Li W, Yang K. Noninvasive diagnosis of liver fibrosis in schistosomiasis japonica: Opportunities and challenges. Portal Hypertens Cirrhosis. 2023;2:43\u20135.","journal-title":"Portal Hypertens Cirrhosis"},{"issue":"6","key":"1485_CR18","first-page":"322","volume":"20","author":"N Chadha","year":"2024","unstructured":"Chadha N, Sterling RK. A clinical review of noninvasive tests for hepatic fibrosis. Gastroenterol Hepatol (N Y). 2024;20(6):322\u20139.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"6","key":"1485_CR19","first-page":"479","volume":"11","author":"C Anania","year":"2011","unstructured":"Anania C, Pacifico L, Ferraro F, Olivero E, Chiesa C. Aspartate transaminase to platelet ratio index (APRI) to assess liver fibrosis in patients with chronic liver disease. Hepat Mon. 2011;11(6):479\u201380.","journal-title":"Hepat Mon"},{"issue":"2","key":"1485_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jfma.2021.07.013","volume":"121","author":"XL Xu","year":"2022","unstructured":"Xu XL, Jiang LS, Wu CS, Pan LY, Lou ZQ, Peng CT, et al. The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: a diagnostic or screening tool? J Formos Med Assoc. 2022;121(2):454\u201366.","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"1485_CR21","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4254\/wjh.v14.i4.696","volume":"14","author":"JC Santos","year":"2022","unstructured":"Santos JC, Pereira CLD, Domingues ALC, Lopes EP. Noninvasive diagnosis of periportal fibrosis in schistosomiasis mansoni: a comprehensive review. World J Hepatol. 2022;14(4):696\u2013707.","journal-title":"World J Hepatol"},{"issue":"1","key":"1485_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13071-022-05359-8","volume":"15","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang P, Li J, Li H, Zhou C, Zhang Y, et al. Association between serum lipid profile and liver fibrosis in patients infected with Schistosoma japonicum. Parasit Vectors. 2022;15(1):268.","journal-title":"Parasit Vectors"},{"issue":"3","key":"1485_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012033","volume":"18","author":"ES Ockenden","year":"2024","unstructured":"Ockenden ES, Frischer SR, Cheng H, Noble JA, Chami GF. The role of point-of-care ultrasound in the assessment of schistosomiasis-induced liver fibrosis: a systematic scoping review. PLoS Negl Trop Dis. 2024;18(3):e0012033.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1485_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jmu.2017.04.001","volume":"25","author":"YS Lin","year":"2017","unstructured":"Lin YS. Ultrasound evaluation of liver fibrosis. J Med Ultrasound. 2017;25(3):127\u20139.","journal-title":"J Med Ultrasound"},{"key":"1485_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10030541","author":"MM Ahsan","year":"2022","unstructured":"Ahsan MM, Luna SA, Siddique Z. Machine-learning-based disease diagnosis: a comprehensive review. Healthcare (Basel). 2022. https:\/\/doi.org\/10.3390\/healthcare10030541.","journal-title":"Healthcare (Basel)"},{"key":"1485_CR26","volume":"4","author":"B Michael","year":"2026","unstructured":"Michael B, Veerasami H, Jayaprakash N. Artificial intelligence and big data for decoding infectious disease transmission dynamics and outbreak prediction. Decod Infect Transm. 2026;4:100079.","journal-title":"Decod Infect Transm"},{"issue":"1","key":"1485_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01585-5","volume":"21","author":"P Decharatanachart","year":"2021","unstructured":"Decharatanachart P, Chaiteerakij R, Tiyarattanachai T, Treeprasertsuk S. Application of artificial intelligence in chronic liver diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2021;21(1):10.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"1485_CR28","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v32.i2.111737","volume":"32","author":"PG Hernandez-Almonacid","year":"2026","unstructured":"Hernandez-Almonacid PG, Marin-Quintero X. Artificial intelligence in metabolic dysfunction-associated steatotic liver disease: transforming diagnosis and therapeutic approaches. World J Gastroenterol. 2026;32(2):111737.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1485_CR29","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.62347\/KEVQ8263","volume":"17","author":"J Song","year":"2025","unstructured":"Song J, Ma N, Aini R, Yang Y. A machine learning model for non-invasive prediction of advanced liver fibrosis in patients with chronic hepatitis B. Am J Transl Res. 2025;17(7):4939\u201351.","journal-title":"Am J Transl Res"},{"key":"1485_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16020261","author":"NS Souza","year":"2026","unstructured":"Souza NS, Vitorio TCV, Souza RA, Machado MAD, Cotrim HP. Artificial intelligence for fibrosis diagnosis in metabolic-dysfunction-associated steatotic liver disease: a systematic review. Diagnostics (Basel). 2026. https:\/\/doi.org\/10.3390\/diagnostics16020261.","journal-title":"Diagnostics (Basel)"},{"key":"1485_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.08.042","author":"H Zhang","year":"2026","unstructured":"Zhang H, Wu X, Ni W, Wu J, Zhou S, Jia L, et al. Application of machine learning and deep learning in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis. J Adv Res. 2026. https:\/\/doi.org\/10.1016\/j.jare.2025.08.042.","journal-title":"J Adv Res."},{"issue":"6","key":"1485_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012235","volume":"18","author":"Z Guo","year":"2024","unstructured":"Guo Z, Zhao M, Liu Z, Zheng J, Gong Y, Huang L, et al. Feasibility of ultrasound radiomics based models for classification of liver fibrosis due to Schistosoma japonicum infection. PLoS Negl Trop Dis. 2024;18(6):e0012235.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1485_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-62521-1","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, Xie S, Zhou J, Cai Y, Zhang P, Li J, et al. Using blood routine indicators to establish a machine learning model for predicting liver fibrosis in patients with Schistosoma japonicum. Sci Rep. 2024;14(1):11485.","journal-title":"Sci Rep"},{"issue":"3","key":"1485_CR34","first-page":"308","volume":"19","author":"HY Hua","year":"2024","unstructured":"Hua HY, Wang T, Sun F, Huang Y, Ji WX, Zhang JF, et al. Prospective cohort study on causes of newly developed advanced schistosomiasis: cohort design and baseline characteristics. J Pathog Biol. 2024;19(3):308\u201311.","journal-title":"J Pathog Biol"},{"issue":"6","key":"1485_CR35","first-page":"583","volume":"31","author":"W Li","year":"2019","unstructured":"Li W, Zhang JF, Wu F, Shi L, Xiong CR, Yao YY, et al. Progress of interruption of schistosomiasis transmission in Jiangsu province. Chin J Schistosomiasis Contr. 2019;31(6):583\u201390 (in Chinese).","journal-title":"Chin J Schistosomiasis Contr"},{"key":"1485_CR36","volume-title":"Ultrasound in schistosomiasis: a practical guide to the standard use of ultrasonography for assessment of schistosomiasis-related morbidity","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Ultrasound in schistosomiasis: a practical guide to the standard use of ultrasonography for assessment of schistosomiasis-related morbidity. Niamey: WHO; 2000."},{"issue":"12","key":"1485_CR37","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1007\/s11695-024-07548-z","volume":"34","author":"CH Lu","year":"2024","unstructured":"Lu CH, Wang W, Li YJ, Chang IW, Chen CL, Su CW, et al. Machine learning models for predicting significant liver fibrosis in patients with severe obesity and nonalcoholic fatty liver disease. Obes Surg. 2024;34(12):4393\u2013404.","journal-title":"Obes Surg"},{"issue":"11","key":"1485_CR38","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1016\/j.cgh.2024.06.014","volume":"22","author":"F Rui","year":"2024","unstructured":"Rui F, Xu L, Yeo YH, Xu Y, Ni W, Tan Y, et al. Machine learning-based models for advanced fibrosis and cirrhosis diagnosis in chronic hepatitis B patients with hepatic steatosis. Clin Gastroenterol Hepatol. 2024;22(11):2250-60 e12.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1485_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102419","volume":"68","author":"F Rui","year":"2024","unstructured":"Rui F, Yeo YH, Xu L, Zheng Q, Xu X, Ni W, et al. Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study. EClinicalMedicine. 2024;68:102419.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"1485_CR40","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1016\/S2589-7500(21)00270-3","volume":"4","author":"SS Sarvestany","year":"2022","unstructured":"Sarvestany SS, Kwong JC, Azhie A, Dong V, Cerocchi O, Ali AF, et al. Development and validation of an ensemble machine learning framework for detection of all-cause advanced hepatic fibrosis: a retrospective cohort study. Lancet Digit Health. 2022;4(3):e188\u201399.","journal-title":"Lancet Digit Health"},{"issue":"4","key":"1485_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S2468-1253(24)00437-0","volume":"10","author":"A Liguori","year":"2024","unstructured":"Liguori A, Zoncape M, Casazza G, Easterbrook P, Tsochatzis EA. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2024;10(4):332\u201349.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"1485_CR42","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"2","key":"1485_CR43","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"key":"1485_CR44","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.14841.1","author":"R Weiskirchen","year":"2018","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Res. 2018. https:\/\/doi.org\/10.12688\/f1000research.14841.1.","journal-title":"F1000Res"},{"key":"1485_CR45","doi-asserted-by":"publisher","first-page":"1035765","DOI":"10.3389\/fcimb.2022.1035765","volume":"12","author":"Z Liu","year":"2022","unstructured":"Liu Z, Zhang L, Liang Y, Lu L. Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis. Front Cell Infect Microbiol. 2022;12:1035765.","journal-title":"Front Cell Infect Microbiol"},{"key":"1485_CR46","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining. San Francisco. California: Association for Computing Machinery; 2016. p. 785\u201394.","DOI":"10.1145\/2939672.2939785"},{"issue":"17","key":"1485_CR47","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1056\/NEJMra2403308","volume":"393","author":"L Castera","year":"2025","unstructured":"Castera L, Rinella ME, Tsochatzis EA. Noninvasive assessment of liver fibrosis. N Engl J Med. 2025;393(17):1715\u201329.","journal-title":"N Engl J Med"},{"issue":"14","key":"1485_CR48","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1056\/NEJMra1814259","volume":"380","author":"A Rajkomar","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019;380(14):1347\u201358.","journal-title":"N Engl J Med"},{"issue":"1","key":"1485_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63095-8","volume":"14","author":"C Zhang","year":"2024","unstructured":"Zhang C, Shu Z, Chen S, Peng J, Zhao Y, Dai X, et al. A machine learning-based model analysis for serum markers of liver fibrosis in chronic hepatitis B patients. Sci Rep. 2024;14(1):12081.","journal-title":"Sci Rep"},{"key":"1485_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cmpb.2018.12.032","volume":"170","author":"CC Wu","year":"2019","unstructured":"Wu CC, Yeh WC, Hsu WD, Islam MM, Nguyen PAA, Poly TN, et al. Prediction of fatty liver disease using machine learning algorithms. Comput Methods Progr Biomed. 2019;170:23\u20139.","journal-title":"Comput Methods Progr Biomed"},{"issue":"4","key":"1485_CR51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nmeth.4642","volume":"15","author":"D Bzdok","year":"2018","unstructured":"Bzdok D, Altman N, Krzywinski M. Statistics versus machine learning. Nat Methods. 2018;15(4):233\u20134.","journal-title":"Nat Methods"},{"issue":"2","key":"1485_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2025.19615","volume":"335","author":"H Tilg","year":"2026","unstructured":"Tilg H, Petta S, Stefan N, Targher G. Metabolic dysfunction-associated steatotic liver disease in adults: a review. JAMA. 2026;335(2):163\u201374.","journal-title":"JAMA"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-026-01485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40249-026-01485-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-026-01485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:16:15Z","timestamp":1787238975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40249-026-01485-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1186\/s40249-026-01485-y","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"90"}}